<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The morphologic and immunohistochemical profiles of gastric mucosa and of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> were assessed in Siewert type I, type II, and gastric antrum <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Sixty-two patients, prospectively operated upon, were included in the study: 37 type II, 15 type I, and 10 antrum <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Samples of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, the surrounding area, and the gastric corpus and antrum were analyzed histologically, and immunostained for cytokeratins (CK)7/20 (staining positive for cells labeled &gt; or = 50%) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Among the 37 type II <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> were the following: (1) 13 of 37 (35%) had <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) in the stomach; (2) 24 of 37 (65%) did not show IM at any level; (3) 34 of 37 (92%) had Helicobacter pylori (HP) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>; (4) 13 of 37(35%) had CK7/20 expression of "Barrett's type" (CK7+/20-); 24 of 37 (65%) had a "no Barrett's type" profile (10 of 37 with CK7-/CK20+ and 14 of 37 with CK7+/CK20+); (5) 100% showed the same CK immunoprofile, both in IM and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (measure of agreement k = 1, p = 0.000) </plain></SENT>
<SENT sid="4" pm="."><plain>Type I <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> showed the following: (1) 87.5% CK Barrett's type, both in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, and in the surrounding IM; (2) 100% gastric samples devoid of both IM and HP <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Comparison between CK immunoprofiles in type I and type II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showed a difference within the two groups (p = 0.002) </plain></SENT>
<SENT sid="6" pm="."><plain>One hundred percent of antrum <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> showed a no Barrett's type CK profile, both in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and in the IM of the entire stomach </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Data suggest that type II <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cannot be always considered a <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo>-related <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>; other pathogenetic pathways should be taken into consideration </plain></SENT>
</text></document>